Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT05795101
TRUDI: TDXD+Durva in HER2+/Low IBC
63 Enrollment(s)
3 Study location(s)
INTERVENTIONAL (PHASE2)
Invasive Breast Cancer


Inflammatory Breast Cancer Stage III


HER2-positive Breast Cancer


HER2 Low Breast Adenocarcinoma


Breast Cancer
RECRUITING
NCT03424005
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
1,132 Enrollment(s)
55 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Metastatic Breast Cancer
RECRUITING
NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
32 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Migraine Disease


Patent Foramen Ovale
NOT_YET_RECRUITING
NCT07862517
Testing the Investigational Medication Combination of Azacitidine, Venetoclax, and Quizartinib Compared to the Usual Treatment of Cytarabine, Daunorubicin, and Quizartinib for Patients With FLT3-ITD Mutant Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
122 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
RECRUITING
NCT07025148
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
40 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)


Percutaneous Coronary Intervention (PCI)
RECRUITING
NCT06588595
The Switching Antiplatelet-9 (SWAP-9) Study
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Arterial Disease (CAD)
COMPLETED
NCT03529110
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
524 Enrollment(s)
164 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT06840886
A Study of PHST001 in Advanced Solid Tumors
426 Enrollment(s)
20 Study location(s)
INTERVENTIONAL (PHASE1)
Advanced Solid Tumors


Ovarian Cancer


Endometrial Cancer


Cholangiocarcinoma


CNS Tumor


Breast Cancer


Fallopian Tube Cancer


Primary Peritoneal Carcinoma


Carcinosarcoma, Ovarian